SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-300792
Filing Date
2013-07-25
Accepted
2013-07-24 17:44:23
Documents
5
Period of Report
2013-07-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d573228d8k.htm 8-K 16705
2 EX-99.1 d573228dex991.htm EX-99.1 7880
3 EX-99.2 d573228dex992.htm EX-99.2 13416
4 GRAPHIC g573228ex.jpg GRAPHIC 12926
5 GRAPHIC g573228ex99_1pg01.jpg GRAPHIC 9976
  Complete submission text file 0001193125-13-300792.txt   71139
Mailing Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 13984416
SIC: 2835 In Vitro & In Vivo Diagnostic Substances